PFBT
MDCX

Parkside Financial Bank & Trust’s Medicus Pharma MDCX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-400
Closed -$1.2K – 2831
2025
Q2 		$1.2K Buy
+400
New +$1.6K ﹤0.01% 2194

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BWM
Base Wealth Management Lakewood Ranch, Florida $215M AUM 19.13% 1-Year Est. Return

Parkside Financial Bank & Trust's MDCX Position: Q3 2025 in Review

Parkside Financial Bank & Trust sold out of Medicus Pharma (MDCX) in Q3 2025, closing a stake of 400 shares — an estimated $1.2K sold.

Parkside Financial Bank & Trust first reported a position in MDCX in Q2 2025 and held it in 1 quarter. The position peaked at $1.2K in Q2 2025. 20 funds tracked by Wall St. Rank hold MDCX as of Q3 2025.

  • Parkside Financial Bank & Trust reported no remaining Medicus Pharma position as of Q3 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 400 Medicus Pharma shares in Q3 2025, an estimated $1.2K.
  • Parkside Financial Bank & Trust first reported a position in Medicus Pharma in Q2 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Medicus Pharma position peaked at $1.2K in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Medicus Pharma as of Q3 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.